
Paul B. Chapman, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, professor of medicine at the Weill Cornell Medical College, discusses targeted treatments for non-traditional mutations in melanoma.

Your AI-Trained Oncology Knowledge Connection!


Published: January 18th 2018 | Updated: